Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (24)

2023

  1. B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease

    Clinical science (London, England : 1979), Vol. 137, Núm. 17, pp. 1409-1429

  2. Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease

    Science translational medicine, Vol. 15, Núm. 712, pp. eabn5939

2022

  1. Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 9, Núm. 3

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. The ANDANTE Project: A Worldwide Individual Data Meta-Analysis of the Effect of Sleep Apnea Treatment on Blood Pressure

    Archivos de Bronconeumologia

2020

  1. Berry fruits modulate kidney dysfunction and urine metabolome in Dahl salt-sensitive rats

    Free Radical Biology and Medicine, Vol. 154, pp. 119-131

  2. Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges

    Respiratory Medicine and Research

2019

  1. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

    Database, Vol. 2019, pp. 1-67

2018

  1. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy

    EMBO Molecular Medicine, Vol. 10, Núm. 8

  2. Five-year risk of stroke after TIA or minor ischemic stroke

    New England Journal of Medicine, Vol. 378, Núm. 23, pp. 2182-2190

2017

  1. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (Nature Genetics (2014) 46 (736-741))

    Nature Genetics

2015

  1. Gut microbiota interacts with brain microstructure and function

    Journal of Clinical Endocrinology and Metabolism, Vol. 100, Núm. 12, pp. 4505-4513

2014

  1. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

    Nature Genetics, Vol. 46, Núm. 7, pp. 736-741

2013

  1. How is intensive care reimbursed? A review of eight European countries

    Annals of Intensive Care, Vol. 3, Núm. 1, pp. 1-9

  2. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy

    Brain, Vol. 136, Núm. 8, pp. 2432-2443

2010

  1. Pathological aspects of lipid peroxidation

    Free Radical Research, Vol. 44, Núm. 10, pp. 1125-1171

2009

  1. Hyperglycemia and glycation in diabetic complications

    Antioxidants and Redox Signaling, Vol. 11, Núm. 12, pp. 3071-3109

2008

  1. New evidences of gene and environment interactions affecting prenatal neurodevelopment in schizophrenia-spectrum disorders: A family dermatoglyphic study

    Schizophrenia Research, Vol. 103, Núm. 1-3, pp. 209-217

2001

  1. Low doses of Epo activate MAP Kinases but not JAK2 - STAT5 in rat vascular smooth muscle cells

    Biochemical and Biophysical Research Communications, Vol. 284, Núm. 4, pp. 1031-1038

  2. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist

    Endocrinology, Vol. 142, Núm. 9, pp. 3950-3963